Skip to content
DeepHealth Brain

Population Health

DeepHealth Brain

Assess and monitor neurodegenerative changes with quantitative and reference data

DeepHealth Brain

DeepHealth Brain is an AI-powered clinical imaging solution for brain atrophy quantification and white matter hyperintensities (WMH) detection. It supports the assessment and monitoring of neurodegenerative changes with quantitative and reference data. FDA-cleared and CE-marked, DeepHealth Brain seamlessly integrates into existing workflows, with results, reports, and segmentations exported directly to PACS. It offers flexible deployment options, including on-site or cloud-based installation.

Book a demo

Brain atrophy analysis

WMH analysis

Comprehensive reports

Automated segmentation

“Using DeepHealth Brain enables us to provide our clinicians with valuable objective information derived from our MRI scans. Comparing the patient's results to a non-biased reference population makes it easier for clinicians to give patients insights into their atrophy development.”

Mario Muto

Director Diagnostic and Interventional Neuroradiology unit at Cardarelli Hospital, Naples

“During our MDT meetings, we always pull up the report from DeepHealth Brain and use it as extra information to come to a joint decision on the best diagnosis and clinical management of the patient.“

Meike Vernooij

Professor of Population Imaging at Erasmus MC, Rotterdam

Learn more

RadNet’s DeepHealth, Inc. Signs First Customer Commitment to Deploy a Suite of Solutions Powered by DeepHealth OS
press release

RadNet’s DeepHealth, Inc. Signs First Customer Commitment to Deploy a Suite of Solutions Powered by DeepHealth OS

LOS ANGELES, California, November 7, 2024 – RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers, announced today that ONRAD, Inc. (“ONRAD”), a national full-service radiology provider has selected RadNet’s DeepHealth OS to advance its next generation of radiology services.

Read more
GE HealthCare and RadNet Forge Collaboration to Transform Imaging Systems and Accelerate the Adoption of Artificial Intelligence (AI) with SmartTechnology™
press release

GE HealthCare and RadNet Forge Collaboration to Transform Imaging Systems and Accelerate the Adoption of Artificial Intelligence (AI) with SmartTechnology™

November 11, 2024: Today, GE HealthCare (Nasdaq: GEHC) and DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), announced a strategic collaboration to further the innovation, commercialization, and adoption of AI in imaging.

Read more
RadNet, Inc. to Acquire iCAD, Inc. to Accelerate AI-Powered Early Detection and Diagnosis of Breast Cancer
press release

RadNet, Inc. to Acquire iCAD, Inc. to Accelerate AI-Powered Early Detection and Diagnosis of Breast Cancer

Los Angeles, CA and Nashua, NH – April 15, 2025, RadNet, Inc. (NASDAQ: RDNT) (“RadNet”), a national leader in providing high-quality, cost-effective diagnostic imaging services and digital health solutions, and iCAD, Inc. (NASDAQ: ICAD) (“iCAD”), a global leader in providing clinically proven AI-powered breast health solutions, announced today that they have entered into a definitive merger agreement under which RadNet will acquire iCAD in an all stock transaction.

Read more
Disclaimers: DeepHealth Brain is manufactured as Quantib ND by Quantib BV for DeepHealth Inc. Not all products and functionalities are commercially available in all countries. For clearance and commercial availability in your geography of functionalities listed and compatibility with other systems, please contact us.